NasdaqCM - Nasdaq Real Time Price USD

Applied DNA Sciences, Inc. (APDN)

Compare

0.1934

-0.0043

(-2.18%)

At close: January 13 at 4:00:01 PM EST

No Tool

Measure

UNDO

Redo

All

Favorites

Text

Statistics

Technicals

Fibonacci

Markings

Lines

Annotation

Arrow

Line

Horizontal

Vertical

Rectangle

Trend Line

Measurement Line

Average Line

Callout

Channel

Check

Continuous

Crossline

Elliott Wave

Ellipse

Doodle

Fib Projection

Fib Arc

Fib Fan

Fib Time Zone

Focus

Gann Fan

Gartley

Heart

Pitchfork

Quadrant Lines

Ray

Regression Line

Fib Retracement

Star

Speed Resistance Arc

Speed Resistance Line

Time Cycle

Tirone Levels

Volume Profile

Cross

Loading Chart for APDN

Applied DNA Completes Buildout of GMP Facility for LineaDNA IVT Templates

Applied DNA Reschedules Investor Update Call in Observance of the National Day of Mourning in Recognition of the Passing of Former President Jimmy Carter

Applied DNA Customer ÚHKT Initiates Phase I Clinical Trial for Rapidly Manufacturable CAR T-Cell Therapy Produced from Linea DNA

Applied DNA Sciences (APDN) Reports Q4 Loss, Tops Revenue Estimates

Applied DNA Sciences: Fiscal Q4 Earnings Snapshot

Applied DNA Announces Fourth Quarter and Fiscal Year 2024 Financial Results, Announces Strategic Restructuring to Prioritize the Manufacture of Critical Starting Materials for Genetic Medicines

Applied DNA to Report Fourth Quarter and Fiscal Year 2024 Financial Results After Market Close on December 17, 2024; Sets Webcast and Conference Call for January 9, 2025, to Coincide with Update on GMP Manufacturing Facility Build-out

Applied DNA Announces Pricing of $6.5 Million Registered Direct Offering and Concurrent Private Placement

Applied DNA to Participate in the 2024 Maxim Healthcare Virtual Summit on Wednesday, October 16